Blood test detects colon cancer
Blood test developed by Guardant Health
A blood test could become an accepted form of colorectal cancer screening. A study published in The New England Journal of Medicine found that a blood test developed by Guardant Health detected colorectal cancer in 83 percent of people who had the disease. That is similar to rates of detection from stool-based colorectal cancer screening tests.
The blood test detects cancer signals in DNA that’s shed from a cancerous tumor. If tumor material is found in the blood, then a colonoscopy would determine whether cancer is present.
The American Cancer Society noted 152,810 new cases of the cancer and 53,010 deaths are forecasted for 2024.
source:
Guardant Health Shield blood test
